Untreated depression during pregnancy: Short- and long-term effects in offspring. A systematic review

Neuroscience

Volumn 342, Issue , 2017, Pages 154-166

  Gentile, S ^a,b  

^a Mental Health Centre n 63   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

child outcomes; pregnancy; prenatal depression

Indexed keywords

NERVE GROWTH FACTOR;

ALCOHOL CONSUMPTION; BODY MASS; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CPG ISLAND; DISEASE SEVERITY; DNA METHYLATION; EDINBURGH POSTNATAL DEPRESSION SCALE; EPIGENETICS; FETUS HEART RATE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LOW BIRTH WEIGHT; MATERNAL AGE; MENTAL DISEASE; NEONATAL INTENSIVE CARE UNIT; PATIENT HEALTH QUESTIONNAIRE 9; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; PUERPERAL DEPRESSION; REACTION TIME; REVIEW; SYSTEMATIC REVIEW; VERTICAL TRANSMISSION; COMPLICATION; DEPRESSION; FEMALE; PATHOPHYSIOLOGY; PREGNANCY;

DEPRESSIVE DISORDER; FEMALE; HUMANS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84945369533     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.09.001     Document Type: Review

References (96)

1. Allister, L., Lester, B.M., Carr, S., Jing Liu, J., The effects of maternal depression on fetal heart rate response to vibroacoustic stimulation. Develop Neuropsychol 20 (2001), 639–651.
2. Altemus, M., Neeb, C.C., Davis, A., Occhiogrosso, M., Nguyen, T., Bleiberg, K.L., Phenotypic differences between pregnancy-onset and postpartum-onset major depressive disorder. J Clin Psychiatry 73 (2012), e1485–e1491.
3. Andersson, L., Sundström-Poromaa, I., Wulff, M., Åström, M., Bixo, M., Implications of antenatal depression and anxiety for obstetric outcome. Obstet Gynecol 104 (2004), 467–476.
4. Andersson, L., Sundström-Poromaa, I., Wulff, M., Åström, M., Bixo, M., Neonatal outcome following maternal antenatal depression and anxiety: a population-based study. Am J Epidemiol 159 (2004), 872–881.
5. Andersson, L., Sundström-Poromaa, I., Bixo, M., Wulff, M., Bondestam, K., Åsrtröm, M., Point prevalence of psychiatric disorders during the second trimester of pregnancy: a population-based study. Am J Obstet Gynecol 89 (2003), 148–154.
6. Ashman, S.B., Dawson, G., Panagiotides, H., Yamada, E., Wilkinson, C.W., Stress hormone levels of children of depressed mothers. Develop Psychopathol 14 (2002), 333–349.
7. Barker, E.D., Kirkham, N., Ng, J., Jensen, S.K.G., Prenatal maternal depression symptoms and nutrition, and child cognitive function. Br J Psychiatry 203 (2013), 417–421.
8. Bennett, I.M., Marcus, S.C., Palmer, S.C., Coyne, J.C., Pregnancy-related discontinuation of antidepressants and depression care visits among Medicaid recipients. Psychiatr Serv 61 (2010), 386–391.
9. Bérard, A., Ramos, E., Rey, E., Blais, L., St-Andrè, M., Oraichi, D., First trimester exposure to paroxetine and risk of cardiac malformations in the infants: the importance of dosage. Birth Def Res Part B Develop Reprod Toxicol 80 (2007), 18–27.
10. Bjørnebekk, A., Siqveland, T.S., Haabrekke, K., Moe, V., Slinning, K., Fjell, A.M., Walhovd, K.B., Development of children born to mothers with mental health problems: subcortical volumes and cognitive performance at 4½ years. Eur Child Adolesc Psychiatry 24 (2015), 115–118.
11. Brazelton, T.B., Nugent, J.K., Lester, B.M., The neonatal behavioral assessment scale. Osofsky, J., (eds.) The handbook of infant development, 1987, Wiley, New York, 780–817.
12. Brennan, P.A., Pargas, R., Walker, E.F., Green, P., Newport, D.J., Stowe, Z., Maternal depression and infant cortisol: influences of timing, comorbidity and treatment. J Child Psychol Psychiatry 49 (2008), 1099–1107.
13. Buss, C., Davis, E.P., Shahbaba, B., Pruessner, J.C., Head, K., Sandman, C.A., Maternal cortisol over the course of pregnancy and subsequent child amygdala and hippocampus volumes and affective problems. Proc Natl Acad Sci U S A 109 (2012), E1312–E1319.
14. Cantwell, R., Oates, M.R., Deaths from psychiatric causes (from the Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom, 2006–2008, Chapter 11). Br J Obstet Gynaecol 118:Suppl. 1 (2011), 132–142.
15. Casper, R.C., Fleisher, B.E., Lee-Ancajas, J.C., et al. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 142 (2003), 402–408.
16. Chang, H.Y., Keyes, K.M., Lee, K.S., et al. Prenatal maternal depression is associated with low birth weight through shorter gestational age in term infants in Korea. Early Hum Develop 90 (2014), 15–20.
17. Chung, T.K.H., Lau, T.K., Yip, A.S.K., Chiu, H.F.K., Lee, D.T.S., Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes. Psychosomatic Med 63 (2001), 830–834.
18. Cohen, L.S., Altshuler, L.L., Harlow, B.L., et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 295 (2006), 499–507.
19. Dayan, J., Creveuil, C., Herlicoviez, M., et al. Role of anxiety and depression in the onset of spontaneous preterm labor. Am J Epidemiol 55 (2002), 293–301.
20. Davidson, R.J., Affective style and affective disorders: perspectives from affective neuroscience. Cogn Emot 12 (1998), 307–320.
21. Diego, M.A., Field, T., Hernandez-Reif, M., Prepartum, postpartum and chronic depression effects on neonatal behavior. Inf Behav Develop 28 (2005), 155–164.
22. Diego, M.A., Field, T., Hernandez-Reif, M., Cullen, C., Schanberg, S., Kuhn, C., Prepartum, postpartum, and chronic depression effects on newborns. Psychiatry 67 (2004), 63–80.
23. Dieter, J.N.I., Field, T., Hernandez-Reif, M., et al. Maternal depression and increased fetal activity. J Obstet Gynaecol 21 (2001), 468–473.
24. Dietz, P.M., Williams, S.B., Callaghan, W.M., Bachman, D.J., Whitlock, E.P., Hornbrook, M.C., Clinically identified maternal depression before, during, and after pregnancies ending in live births. Am J Psychiatry 164 (2007), 1515–1520.
25. Dhobale, M.V., Pisal, H.R., Mehendale, S.S., Joshi, S.R., Differential expression of human placental neurotrophic factors in preterm and term deliveries. Int J Dev Neurosci 31 (2013), 719–723.
26. Ebeid, E., Nassif, N., Sinha, P., Prenatal depression leading to postpartum psychosis. J Obstet Gynaecol 30 (2010), 435–438.
27. El Marroun, H., White, T.J.H., van der knaap, N.F.J., et al. Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children. Br J Psychiatry 205 (2014), 95–102.
28. Emory, E.K., Dieter, J.N.I., Maternal depression and psychotropic medication effects on the human fetus. Ann N Y Acad Sci 1094 (2006), 287–291.
29. Engelstad, H.J., Roghair, R.D., Calarge, C.A., Colaizy, T.T., Stuart, S., Haskell, S.E., Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapy. Neonatology 105 (2014), 149–154.
30. Ertel, K.A., Koenen, K.C., Rich-Edwards, J.W., Gillman, M.W., Maternal depressive symptoms not associated with reduced height in young children in a US prospective cohort study. PLoS One, 5, 2010, e13656.
31. Ertel, K.A., Koenen, K.C., Rich-Edwards, J.W., Gillman, M.W., Antenatal and postpartum depressive symptoms are differentially associated with early childhood weight and adiposity. Paediatr Perinatol Epidemiol 24 (2010), 179–189.
32. Farias, D.R., Pereira Pinto, T.J., Teofilo, M.M.T., et al. Prevalence of psychiatric disorders in the first trimester of pregnancy and factors associated with current suicide risk. Psychiatry Res 210 (2013), 962–968.
33. Field, T., Diego, M., Hernandez-Reif, M., Prenatal dysthymia versus major depression effects on the neonate. Inf Behav Develop 31 (2008), 190–193.
34. Field, T., Diego, M., Dieter, J., et al. Prenatal depression effects on the fetus and the newborn. Inf Behav Develop 27 (2004), 216–229.
35. Field, T., Hernandez-Reif, M., Schamberg, S., et al. Pregnancy anxiety and comorbid depression and anger: effects on the fetus and neonate. Depress Anx 17 (2003), 140–151.
36. Field, T., Diego, M., Schamberg, S., et al. Prenatal depression effects on the fetus and neonate in different ethnic and socio-economic status groups. J Repr Infant Psychol 20 (2002), 149–157.
37. Field, T., Fox, N.A., Pickens, J., et al. Relative right frontal EEG activation in 3- to 6-month-old infants of “depressed” mothers. Develop Psychol 31 (1995), 358–363.
38. Field, T., Pickens, J., Fox, N.A., et al. Vagal tone in infants of depressed mothers. Develop Psychopathol 7 (1995), 227–231.
39. Field, T., Sandberg, D., Garcia, R., Vega-Lahr, N., Goldstein, S., Guy, L., Pregnancy problems, postpartum depression, and early mother-infant interactions. Develop Psychol 23 (1985), 1152–1156.
40. Figueiredo, B., Pacheco, A., Costa, R., Depression during pregnancy and the postpartum period in adolescent and adult Portuguese mothers. Arch Wom Ment Health 10 (2007), 103–109.
41. Figueiredo, B., Conde, A., Anxiety and depression in women and men from early pregnancy to 3-months postpartum. Arch Wom Ment Health 14 (2011), 247–255.
42. Fox, N.A., Davidson, R.J., Taste-elicited changes in facial signs of emotion and the asymmetry of brain electric activity in newborns. Neuropsychologia 24 (1986), 417–422.
43. Freitas, G.V.S., Cais, C.F.S., Stefanello, S., Botega, N.J., Psychosocial conditions and suicidal behavior in pregnant teenagers. A case-control study in Brazil. Eur Child Adolesc Psychiatry 17 (2008), 336–342.
44. Gagnon, R., Stimulation of human fetus with sound and vibration. Sem Perinatol 13 (1989), 393–402.
45. Galbally, M., Lewis, A., Gentile, S., Buist, A., Maternal antidepressant treatment in pregnancy and child developmental outcomes. Arch Wom Ment Health, 16(Suppl. 1), 2013, S53.
46. Gentile, S., Prenatal antidepressant exposure and the risk of Autism Spectrum Disorders in children. Are we looking at the falls of Gods??. J Aff Disord 182 (2015), 132–137.
47. Gentile, S., Managing antidepressant treatment in pregnancy and puerperium. Careful with that axe, Eugene. Exp Opin Drug Saf 14 (2015), 1011–1014.
48. Gentile, S., Bipolar disorder and pregnancy: to treat or not to treat?. Br Med J, 345, 2012, e7367.
49. Gentile, S., On categorizing gestational birth, and neonatal complications following late in utero exposure to antidepressants. The prenatal antidepressant exposure syndrome. CNS Spectr 15 (2010), 167–185.
50. Gentile, S., Neurodevelopmental effects of prenatal exposure to psychotropic medications. Depress Anx 27 (2010), 675–686.
51. Gentile, S., Pregnancy exposure to SRIs and the risk of spontaneous abortions: a critical review. CNS Spectr 13 (2008), 960–966.
52. Gentile, S., SSRIs in pregnancy and lactation with emphasis on neurodevelopmental outcome. CNS Drugs 19 (2005), 623–633.
53. Gentile, S., Galbally, M., Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: a systematic review. J Affect Disord 128 (2011), 1–9.
54. Goldstein, D.J., Corbin, L.A., Sundell, K.L., Effects of first-trimester fluoxetine exposure on the newborn. Obstet Gynecol 89 (1997), 713–718.
55. Hayes, L.J., Goodman, S.H., Carlson, E., Maternal antenatal depression and infant disorganized attachment at 12 months. Attach Hum Develop 15 (2013), 133–153.
56. Hoffman, S., Maureen, C., Hatch, M.C., Depressive symptomatology during pregnancy: evidence for an association with decreased fetal growth in pregnancies of lower social class women. Health Psychol 19 (2000), 535–543.
57. Hornbrook, M.C., Clinically identified maternal depression before, during, and after pregnancies ending in live births. Am J Psychiatry 164 (2007), 1515–1520.
58. Katon, W.J., Russo, J.E., Katon, J.G., Gavin, A.R., Melville, J.L., Depression in pregnancy is associated with preexisting but not pregnancy-induced hypertension. Gen Hosp Psychiatry 34 (2012), 9–16.
59. Kaihola, H., Olivier, J., Poromaa, I.S., Åkerud, H., The effect of antenatal depression and Selective Serotonin Reuptake Inhibitor treatment on Nerve Growth Factor signaling in human placenta. PLoS One, 10, 2015, e0116459, 10.1371/journal.pone.0116459.
60. Kennard, B., Hughes, B.A., Stewart, S.M., et al. Maternal depressive symptoms in pediatric major depressive disorder: relationship with acute treatment outcome. J Am Acad Child Adol Psychiatry, 47, 2008 694-669.
61. Kumar, R., Robson, M.K., A prospective study of emotional disorder in childbearing women. Br J Psychiatry 144 (1984), 35–47.
62. Lancaster, C.A., Gold, K.J., Flynn, H.A., Yoo, H., Marcus, S.M., Davis, M.M., Risk factors for depressive symptoms during pregnancy: a systematic review. Am J Obstet Gynecol 202 (2010), 5–14.
63. Lester BM (1984) Data analysis and prediction. In: Neonatal behavioral assessment scale, second ed. (Brazelton TB, ed), pp. 85–96. London: Spastics International Medical Publications.
64. Li, D., Liu, L., Odouli, R., Presence of depressive symptoms during early pregnancy and the risk of preterm delivery: a prospective cohort study. Hum Reprod 24 (2008), 146–153.
65. Lundy, L., Jones, N.A., Field, T., et al. Prenatal depression effects on neonates. Inf Behav Develop 22 (1999), 119–129 ANT.
66. Lundy, B., Field, T., Pickens, J., Newborns of mothers with depressive symptoms are less expressive. Inf Behav Develop 19 (1996), 419–424.
67. Luoma, I., Tamminen, T., Kaukonen, P., et al. Longitudinal study of maternal depressive symptoms and child well-being. J Am Acad Child Adolesc Psychiatry 40 (2001), 1367–1374.
68. Mäki, P., Veijolaa, J., Räsänena, P., Joukamaaa, M., Valonenc, P., Jokelainen, J., Isohanni, M., Criminality in the offspring of antenatally depressed mothers: a 33-year follow-up of the Northern Finland 1966 Birth Cohort. J Affect Disord 74 (2013), 273–278.
69. Marcus, S.M., Flynn, H.A., Blow, F.C., Barry, K.L., Depressive symptoms among pregnancy women screened in obstetric settings. J Womens Health 12 (2003), 373–380.
70. Melville, J.L., Gavin, A., Guo, Y., Fan, M.Y., Katon, J., Depressive disorders during pregnancy. Prevalence and risk factors in a large urban sample. Obstetr Gynecol 116 (2010), 1064–1070.
71. Newport, D.J., Levey, L.C., Pennell, P.B., Ragan, K., Stowe, Z.N., Suicidal ideation in pregnancy: assessment and clinical implications. Arch Wom Ment Health 10 (2007), 181–187.
72. Non, A.L., Binder, A.M., Kubzansky, L.D., Michels, K.B., Genome-wide DNA methylation in neonates exposed to maternal depression, anxiety, or SSRI medication during pregnancy. Epigenetics 9 (2014), 1–9.
73. Oberlander, T.F., Warburton, W., Misri, S., Aghajanian, J., Hertzman, C., Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 63 (2006), 898–906.
74. O'Hara, M.W., Zekoski, E.M., Philipps, L.H., Wright, E.J., Controlled prospective study of postpartum mood disorders: comparison of childbearing and nonchildbearing. J Abnorm Psychol 1 (1990), 3–15.
75. Orr, S.T., James, S.A., Prince, C.B., Maternal prenatal depressive symptoms and spontaneous preterm births among African-American women in Baltimore, Maryland. Am J Epidemiol 156 (2002), 797–802.
76. Pariante, C., Depression and antidepressants in pregnancy: molecular and psychosocial mechanisms affecting offspring's physical and mental health. Neuropsychopharmacol Rev 40 (2015), 246–247.
77. Pawlby, S., Hay, D.F., Sharp, D., Waters, C.S., O'Keane, V., Antenatal depression predicts depression in adolescent offspring: prospective longitudinal community-based study. J Affect Disord 113 (2009), 236–243.
78. Pearson, R.M., Evans, J., Kounali, D., et al. Maternal depression during pregnancy and the postnatal period risks and possible mechanisms for offspring depression at age 18 years. JAMA Psychiatry 70 (2013), 1312–1319.
79. Pedersen, L.H., Henriksen, T.B., Olsen, J., Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age. Pediatrics 125 (2010), e600–e608.
80. Petersen, I., Evans, S., Nazareth, I., Prenatal exposure to selective serotonin reuptake inhibitors and autistic symptoms in young children: another red herring?. Br J Psychiatry 205 (2014), 105–106.
81. Petersen, I., Gilbert, R.E., Evans, S.J., Man, S.L., Nazareth, I., Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network. J Clin Psychiatry 72 (2011), 979–985.
82. Qiu, C., Williams, M.A., Calderon-Margalit, R., Cripe, S.M., Sorensen, T.K., Preeclampsia risk in relation to maternal mood and anxiety disorders diagnosed before or during early pregnancy. Am J Hypertension 22 (2009), 397–402.
83. Rahman, A., Iqbal, Z., Bunn, J., Lovel, H., Harrington, R., Impact of maternal depression on infant nutritional status and illness. A cohort study. Arch Gen Psychiatry 61 (2004), 946–952.
84. Şahingöz, M., Yuksel, G., Karsidag, C., et al. Birth weight and preterm birth in babies of pregnant women with major depression in relation to treatment with antidepressants. J Clin Psychopharmacol 34 (2014), 226–229.
85. Steer, R.A., Scholl, T.O., Hediger, M.L., Fischer, R.L., Self-reported depression and negative pregnancy outcome. J Clin Epidemiol 45 (1992), 1093–1099.
86. Stewart, D.E., Clinical practice: depression during pregnancy. New Engl J Med 365 (2011), 1605–1611.
87. Suri, R., Altshuler, L., Hellemann, G., Burt, V.K., Aquino, A., Mintz, J., Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry 164 (2007), 1206–1213.
88. Suri, R., Altshuler, L., Hendrick, V., Rasgon, N., Lee, E., Mintz, J., The impact of depression and fluoxetine treatment on obstetrical outcome. Arch Wom Ment Health 7 (2004), 193–200.
89. Tharner, A., Luijk, M.P.C.M., van Ijzndoorn, M.H., et al. Maternal lifetime history of depression and depressive symptoms in the prenatal amd postnatal period do not predict infant-mother attachment quality in a large, population-based Dutch cohort study. Attach Hum Develop 14 (2012), 63–81.
90. Viguera, A.C., Tondo, L., Koukopulos, A.E., et al. Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am J Psychiatry 168 (2011), 1179–1185.
91. Wisner, K.L., Sit, D.K.Y., Hanusa, B.H., et al. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry 166 (2009), 557–566.
92. Yonkers, K.A., Smith, M.V., Forray, A.C., et al. Pregnant women with Posttraumatic Stress Disorder and risk of preterm birth. JAMA Psychiatry 71 (2014), 897–904.
93. Yonkers, K.A., Gotman, N., Smith, M.V., et al. Does antidepressant use attenuate the risk of a major depressive episode in pregnancy?. Epidemiology 22 (2011), 848–854.
94. Yonkers, K.A., Smith, M.V., Gotman, N., Belanger, K., Typical somatic symptoms of pregnancy and their impact on a diagnosis of major depressive disorder. Gen Hosp Psychiatry 31 (2009), 327–333.
95. Yonkers, K.A., Wisner, K.L., Stewart, D.E., et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynaecologists. Gen Hosp Psychiatry 31 (2009), 403–413.
96. Zax, M., Sameroff, A.J., Babigian, H.M., Birth outcomes in the offspring of mentally disordered women. Am J Orthopsy 47 (1997), 218–230.